Relationship Between Modality-specific Dual-task Performance and Immersive Exergaming Outc
The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answe
| Condition(s) | Healthy Athlete |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answer are: * Can performance in visual and auditory dual-task paradigms explain performance in an immersive exergaming task in healthy athletes? * How are exergaming scores associated with athletic performance tests? * What biomechanical movement patterns are shown during dual-tasks? Researchers will also compare performance of those experienced with jumping and those inexperienced with jumping. Participants will: * Complete two sessions performing athletic performance tests, cog |
| Who can participate | Inclusion Criteria: * age between 18 and 34 years * self-reported recreationally or competitively active (more than 2 hours per week) * self-reported ability to complete change of direction, balancing, and jumping tasks * capacity to sign informed consent * ability to understand German Exclusion Criteria: * acute injury in the last 6 months resulting in missing more than 3 training sessions * severe comorbidity or condition which would prohibit performance of the lsted testing tasks * self-reported pregnancy |
| Ages | 18 Years to 34 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Zurich University of Applied Sciences |
| Locations | Winterthur, Canton of Zurich, Switzerland |
| Start date | 2026-03-24 |
| NCT ID | NCT07461025 |
| Official listing | https://clinicaltrials.gov/study/NCT07461025 |